Burcu Kolukısa

Evolution and long‐term outcomes of combined immunodeficiency due to CARMIL2 deficiency

Burcu Kolukısa, Dilek Başer, Bengü Akçam et al. · Allergy · 2021 · 45 citations · Full text

Adverse COVID‐19 outcomes in immune deficiencies: Inequality exists between subclasses

Elif Karakoç-Aydıner, Sevgi Bilgiç Eltan, Royale Babayeva et al. · Allergy · 2021 · 40 citations · Full text

Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

Romain Lévy, Florian Gothe, Mana Momenilandi et al. · The Journal of Experimental Medicine · 2022 · 35 citations · Full text

Human Carmil2 Deficiency, Adaptive Immune System, Immunodeficiencies +28

Expanding the Clinical and Immunological Phenotypes and Natural History of MALT1 Deficiency

Asena Pınar Sefer, Hassan Abolhassani, Franziska Ober et al. · Journal of Clinical Immunology · 2022 · 31 citations · Full text

Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

Ahmet Özen, Voranush Chongsrisawat, Asena Pınar Sefer et al. · The Lancet · 2024 · 25 citations · Full text

Thrombopoiesis, Thrombosis, Translational Medicine +12